A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Trial · NCT03316300
Adverse events438
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 438
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Basal Cell Carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NT-501 | 1 | 58 | 1 |
| other | Basal Cell Carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Sham | 1 | 57 | 1 |
| other | Eye naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NT-501 | 0 | 58 | 0 |
| other | Eye naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Sham | 1 | 57 | 1 |
| other | Colorectal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NT-501 | 0 | 58 | 0 |
| other | Colorectal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Sham | 1 | 57 | 1 |
| other | Lung carcinoma cell type unspecified recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NT-501 | 1 | 58 | 1 |
| other | Lung carcinoma cell type unspecified recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Sham | 0 | 57 | 0 |
| other | Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | NT-501 | 1 | 58 | 1 |
| other | Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Sham | 0 | 57 | 0 |
| other | Hypertension | Vascular disorders | NT-501 | 1 | 58 | 1 |
| other | Hypertension | Vascular disorders | Sham | 5 | 57 | 5 |
| other | Deep vein thrombosis | Vascular disorders | NT-501 | 1 | 58 | 1 |
| other | Deep vein thrombosis | Vascular disorders | Sham | 0 | 57 | 0 |
| other | Essential hypertension | Vascular disorders | NT-501 | 0 | 58 | 0 |
| other | Essential hypertension | Vascular disorders | Sham | 1 | 57 | 1 |
| other | Raynaud's phenomenon | Vascular disorders | NT-501 | 0 | 58 | 0 |
| other | Raynaud's phenomenon | Vascular disorders | Sham | 1 | 57 | 1 |
| other | Tooth extraction | Surgical and medical procedures | NT-501 | 2 | 58 | 2 |
| other | Tooth extraction | Surgical and medical procedures | Sham | 0 | 57 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03316300/events